Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Hemorrhage Elimination During Lumbar Puncture Using Ultrasound Measurements (HELPUS)

NCT: NCT07612644 · RECRUITING

NCT IDNCT07612644
StatusRECRUITING
Start Date2026-05-16
Completion2028-06-30

Brief Summary

This is a clinical trial to determine the extent to which ultrasound-assisted lumbar puncture using a standardized procedure, including use of ultrasound to ascertain the presence of cerebrospinal fluid (CSF) at L3 - L5 and the optimal needle insertion distance, increases the acquisition rate of CSF that is interpretable for patient management.

Frequently Asked Questions

What is Hemorrhage Elimination During Lumbar Puncture Using Ultrasound Measurements (HELPUS)?

Hemorrhage Elimination During Lumbar Puncture Using Ultrasound Measurements (HELPUS) is a clinical trial registered under NCT07612644. Current status: RECRUITING.

What is the status of NCT07612644?

The current status of NCT07612644 (Hemorrhage Elimination During Lumbar Puncture Using Ultrasound Measurements (HELPUS)) is: RECRUITING.

When did Hemorrhage Elimination During Lumbar Puncture Using Ultrasound Measurements (HELPUS) start?

Hemorrhage Elimination During Lumbar Puncture Using Ultrasound Measurements (HELPUS) started on 2026-05-16.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑